Cargando…

Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock

Endotoxin adsorption therapy by polymyxin B-immobilized fiber column direct hemoperfusion (PMX-DHP) has been used for the treatment of septic shock patients. Endotoxin, an outer membrane component of Gram-negative bacteria, plays an important role in the pathogenesis of septic shock. Endotoxin trigg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitaka, Chieko, Kusaoi, Makio, Kawagoe, Izumi, Satoh, Daizoh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Critical Care Medicine 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182162/ https://www.ncbi.nlm.nih.gov/pubmed/33813808 http://dx.doi.org/10.4266/acc.2021.00150

Ejemplares similares

Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
por: Sugiura, Makiko, et al.
Publicado: (2015)

Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
por: Yamashita, C, et al.
Publicado: (2011)

A successful application of adult polymyxin B-immobilized fiber column hemoperfusion to a neonate with septic shock
por: Kim, Young A, et al.
Publicado: (2019)

Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours
por: Mitaka, C, et al.
Publicado: (2012)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

“Impact of timing of polymyxin B‐immobilized fiber column direct hemoperfusion on outcome in patients with septic shock: a single‐center observational study”
por: Tanaka, Tomoki, et al.
Publicado: (2019)

Efficacy of direct hemoperfusion with a polymyxin B‐immobilized fiber column in miliary tuberculosis
por: Kawano, Yasumasa, et al.
Publicado: (2016)

Beneficial effects of early hemoperfusion with a polymyxin B fibre column on septic shock
por: Takeyama, N, et al.
Publicado: (2009)

Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection
por: Saito, Nobuyuki, et al.
Publicado: (2017)

Suggestions and tips regarding polymyxin B-immobilized fiber column direct hemoperfusion of neonates with sepsis
por: Nishizaki, Naoto
Publicado: (2020)

Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, Hidehiko, et al.
Publicado: (2005)

Hemoperfusion with an immobilized polymyxin B fiber column improves gastric mucosal pH with sepsis patients
por: Kushi, H, et al.
Publicado: (2006)

Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19
por: Katagiri, Daisuke, et al.
Publicado: (2020)

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock
por: Shoji, Hisataka, et al.
Publicado: (2021)

Effectiveness of polymyxin b immobilized fiber hemoperfusion in patients with septic shock due to Gram-negative bacillus infection: the PMXHP study
por: Saito, N, et al.
Publicado: (2015)

Use of Direct Hemoperfusion with Polymyxin B-Immobilized Fiber for the Treatment of Septic Shock Complicated with Lemierre Syndrome Caused by Fusobacterium necrophorum
por: Kodama, Yoshiyuki, et al.
Publicado: (2019)

Early introduction of hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, H, et al.
Publicado: (2005)

Direct hemoperfusion with polymyxin B-immobilized fiber column in a patient with acute exacerbation of idiopathic pulmonary fibrosis
por: Kim, Shin Young, et al.
Publicado: (2020)

Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion
por: Kusaba, Yusaku, et al.
Publicado: (2020)

History and current status of polymyxin B‐immobilized fiber column for treatment of severe sepsis and septic shock
por: Shimizu, Tomoharu, et al.
Publicado: (2017)

Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
por: Ikeda, T, et al.
Publicado: (2012)

Effective use of polymyxin B hemoperfusion in septic shock complicated by urosepsis
por: Malleshappa, P., et al.
Publicado: (2011)

Is polymyxin B-immobilized fiber column ineffective for septic shock? A discussion on the press release for EUPHRATES trial
por: Iba, Toshiaki, et al.
Publicado: (2017)

Oxygen metabolism as an indicator in criteria for hemoperfusion using a polymyxin-B immobilized column introduction
por: Kushi, H, et al.
Publicado: (2005)

Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias
por: Okabayashi, Hiroko, et al.
Publicado: (2017)

Polymyxin-B-immobilized-fiber column hemoperfusion with oseltamivir treatment for ARDS due to influenza H1N1/09
por: Binh, Nguyen Gia, et al.
Publicado: (2015)

Clinical effects of polymyxin B‐immobilized fiber column direct hemoperfusion for severe bacterial meningitis: A series of 10 cases
por: Suzuki, Yoko, et al.
Publicado: (2020)

Polymyxin B-immobilized fiber hemoperfusion therapy improves sepsis-related immunosuppression
por: Kimura, A, et al.
Publicado: (2014)

Polymyxin B hemoperfusion in high endotoxin activity level septic shock patients
por: Monti, G, et al.
Publicado: (2008)

Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
por: Kase, Y, et al.
Publicado: (2009)

Investigation of type II phospholipase A(2 )values and eicosanoid values during polymyxin-B-immobilized fiber direct hemoperfusion of septic shock patients
por: Shouzushima, T, et al.
Publicado: (2009)

Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study
por: Terada-Hirashima, Junko, et al.
Publicado: (2022)

Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival
por: Enomoto, Noriyuki, et al.
Publicado: (2015)

The Characteristics of Patients with Severe COVID-19 Pneumonia Treated with Direct Hemoperfusion Using Polymyxin B-Immobilized Fiber Column (PMX-DHP)
por: Kuwana, Tsukasa, et al.
Publicado: (2022)

White blood cell counts have an impact on septic patient outcome followed by polymyxin-b immobilized fiber with direct hemoperfusion
por: Tanaka, H, et al.
Publicado: (2015)

Prognostic factors in patients with septic shock in digestive surgery who have undergone direct hemoperfusion with polymyxin B-immobilized fibers: a retrospective observational study
por: Matsukuma, Satoshi, et al.
Publicado: (2015)

Polymyxin B-direct hemoperfusion therapy improves mean arterial pressure in septic shock
por: Yokota, Mari, et al.
Publicado: (2013)

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018)

Polymyxin B Hemoperfusion in Pediatric Septic Shock: Single-Center Observational Case Series
por: Saetang, Patcharin, et al.
Publicado: (2022)

Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study
por: Mitaka, Chieko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6edgitaqm0126t9ah3bad30nqi